| A highly sensitive fluorescent micro-assay of H2O2 release from activated human leukocytes using a dihydroxyphenoxazine derivative JG Mohanty, JS Jaffe, ES Schulman, DG Raible Journal of immunological methods 202 (2), 133-141, 1997 | 659 | 1997 |
| A novel lymphoproliferative/autoimmune syndrome resembling murine lpr/gld disease. MC Sneller, SE Straus, ES Jaffe, JS Jaffe, TA Fleisher, ... The Journal of clinical investigation 90 (2), 334-341, 1992 | 368 | 1992 |
| Effects of sirolimus on plasma lipids, lipoprotein levels, and fatty acid metabolism in renal transplant patients JD Morrisett, G Abdel-Fattah, R Hoogeveen, E Mitchell, CM Ballantyne, ... Journal of lipid research 43 (8), 1170-1180, 2002 | 320 | 2002 |
| New insights into common variable immunodeficiency MC Sneller, W Strober, E Eisenstein, JS Jaffe, C Cunningham-Rundles Annals of internal medicine 118 (9), 720-730, 1993 | 257 | 1993 |
| Head-to-head, randomised, crossover study of oral versus subcutaneous methotrexate in patients with rheumatoid arthritis: drug-exposure limitations of oral methotrexate at … MH Schiff, JS Jaffe, B Freundlich Annals of the rheumatic diseases 73 (8), 1549-1551, 2014 | 250 | 2014 |
| Everolimus and reduced-exposure cyclosporine in de novo renal-transplant recipients: a three-year phase II, randomized, multicenter, open-label study B Nashan, J Curtis, C Ponticelli, G Mourad, J Jaffe, T Haas, ... Transplantation 78 (9), 1332-1340, 2004 | 230 | 2004 |
| Effect of sirolimus on the metabolism of apob100-containing lipoproteins in renal transplant patients1 RC Hoogeveen, CM Ballantyne, HJ Pownall, AR Opekun, DL Hachey, ... Transplantation 72 (7), 1244-1250, 2001 | 165 | 2001 |
| STIMULATED RESPONSE OF PERIPHERAL LYMPHOCYTES MAY DISTINGUISH CYCLOSPORINE EFFECT IN RENAL TRANSPLANT RECIPIENTS RECEIVING A CYCLOSPORINE+ RAPAMYCIN REGIMEN1 R Sindhi, MF LaVia, E Paulling, J McMichael, G Burckart, S Shaw, ... Transplantation 69 (3), 432-436, 2000 | 125 | 2000 |
| Cytokine mRNA expression in human platelets and a megakaryocytic cell line and cytokine modulation of platelet function G Soslau, DA Morgan, JS Jaffe, I Brodsky, Y Wang Cytokine 9 (6), 405-411, 1997 | 105 | 1997 |
| Evidence for an abnormal profile of interleukin-4 (IL-4), IL-5, and γ-interferon (γ-IFN) in peripheral blood T cells from patients with allergic eosinophilic gastroenteritis JS Jaffe, SP James, GE Mullins, L Braun-Elwert, I Lubensky, DD Metcalfe Journal of clinical immunology 14, 299-309, 1994 | 100 | 1994 |
| Functional abnormalities of CD8+ T cells define a unique subset of patients with common variable immunodeficiency JS Jaffe, W Strober, MC Sneller | 77 | 1993 |
| Human lung mast cell IL-5 gene and protein expression: temporal analysis of upregulation following IgE-mediated activation. JS Jaffe, MC Glaum, DG Raible, TJ Post, E Dimitry, D Govindarao, ... American journal of respiratory cell and molecular biology 13 (6), 665-675, 1995 | 76 | 1995 |
| Reduced interleukin-2 (IL-2) production in common variable immunodeficiency is due to a primary abnormality of CD4+ T cell differentiation EM Eisenstein, JS Jaffe, W Strober Journal of clinical immunology 13, 247-258, 1993 | 68 | 1993 |
| Human lung mast cell activation leads to IL-13 mRNA expression and protein release. JS Jaffe, DG Raible, TJ Post, Y Wang, MC Glaum, JH Butterfield, ... American journal of respiratory cell and molecular biology 15 (4), 473-481, 1996 | 51 | 1996 |
| Abnormal cytokine expression in Sezary and adult T-cell leukemia cells correlates with the functional diversity between these T-cell malignancies CL Tendler, JD Burton, J Jaffe, D Danielpour, M Charley, JP McCoy, ... Cancer research 54 (16), 4430-4435, 1994 | 50 | 1994 |
| Sirolimus in pediatric gastrointestinal transplantation: the use of sirolimus for pediatric transplant patients with tacrolimus‐related cardiomyopathy PA Pappas, D Weppler, AD Pinna, P Rusconi, JK Thompson, J Jaffe, ... Pediatric transplantation 4 (1), 45-49, 2000 | 49 | 2000 |
| Pharmacokinetic profile of subcutaneous testosterone enanthate delivered via a novel, prefilled single‐use autoinjector: a phase II study J Kaminetsky, JS Jaffe, RS Swerdloff Sexual medicine 3 (4), 269-279, 2015 | 42 | 2015 |
| A 52-week study of dose adjusted subcutaneous testosterone enanthate in oil self-administered via disposable auto-injector JC Kaminetsky, A McCullough, K Hwang, JS Jaffe, C Wang, RS Swerdloff The Journal of Urology 201 (3), 587-594, 2019 | 38 | 2019 |
| Nearly pain-free self-administration of subcutaneous methotrexate with an autoinjector: results of a phase 2 clinical trial in patients with rheumatoid arthritis who have … B Freundlich, A Kivitz, JS Jaffe JCR: Journal of Clinical Rheumatology 20 (5), 256-260, 2014 | 37 | 2014 |
| Safety of a new subcutaneous testosterone enanthate auto-injector: results of a 26-week study M Gittelman, JS Jaffe, JC Kaminetsky The Journal of Sexual Medicine 16 (11), 1741-1748, 2019 | 31 | 2019 |
